Jacob Talbot
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Chitinase-1 in cerebrospinal fluid and white matter injury in patients with progressive multiple sclerosis.
Journal: Journal of neuroimmunology
Published: December 03, 2024
Intrathecal CD8+CD20+ T Cells in Primary Progressive Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: November 16, 2022
Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study.
Journal: Multiple sclerosis and related disorders
Published: November 16, 2022
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: September 26, 2022
Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 24, 2022
Peripheral helper T cells in the pathogenesis of multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 03, 2022
Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS.
Journal: Journal of neuroimmunology
Published: August 16, 2021
Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: March 29, 2021
Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 05, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026